Showing results (701-710 of 1,142) with videos related to
Sort By:
Pageof 115
Journal of Hepatocellular Carcinoma|May 22, 2023
Clinical Results, Risk Factors, and Future Directions of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular CarcinomaTian-Tian Dong, Lan Wang, Ming Li, et al.Journal of Hepatocellular Carcinoma|February 15, 2023
Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1-2 cmPeng Huang, Xiaoyan Ni, Changwu Zhou, et al.Journal of Hepatocellular Carcinoma|February 23, 2023
Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib ResistanceXinhua Zou, Qingyu Xu, Ran You, et al.Journal of Hepatocellular Carcinoma|February 27, 2023
Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib TreatmentKun-Ming Chan, Yin Lai, Hao-Chien Hung, et al.Journal of Hepatocellular Carcinoma|March 6, 2023
ULK1 Depletion Protects Mice from Diethylnitrosamine-Induced Hepatocarcinogenesis by Promoting Apoptosis and Inhibiting AutophagyTing Duan, Xin Yang, Jingyu Kuang, et al.Journal of Hepatocellular Carcinoma|March 24, 2023
The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCCTao Sun, Yanqiao Ren, Bo Sun, et al.Journal of Hepatocellular Carcinoma|August 11, 2016
Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinomaAbdulwahab Ali Gabeen, Fatma Farag Abdel-Hamid, Motawa Eisa El-Houseini, et al.Journal of Hepatocellular Carcinoma|August 11, 2016
New insights on the role of epigenetic alterations in hepatocellular carcinomaMaddalena Frau, Claudio F Feo, Francesco Feo, et al.Journal of Hepatocellular Carcinoma|August 11, 2016
Clinical utility of imaging for evaluation of hepatocellular carcinomaTakamichi Murakami, Masakatsu Tsurusaki, Tomoko Hyodo, et al.Journal of Hepatocellular Carcinoma|August 11, 2016
Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case seriesHarrys A Torres, Ahmed Kaseb, Parag Mahale, et al.Pageof 115